ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,310.59
      0.07%
      US Tech 100
      18,363.60
      0.74%
      Dow Jones
      39,330.09
      -0.86%
      Brent Oil
      81.385
      -0.18%
      Bitcoin
      67,888.00
      -1.76%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. AMEX
      6. Manhattan Pharmaceuticals (MHA)

      7. Manhattan Pharmaceuticals (MHA) News

      MHA

      Manhattan Pharmaceuticals (MHA)

      Manhattan Pharmaceuticals
      		Date:
      Sort by:
       Showing the most relevant articles for your search:AMEX:MHA
      DateTimeSourceHeadlineSymbolCompany
      03/19/200812:35PMEdgar (US Regulatory)Manhattan Pharmaceuticals Inc-Amended Nat'nl Sec. Exchg. Report the Removal from listing & reg. of matured, redeemed/re.. (25/A)AMEX:MHAManhattan Pharmaceuticals
      03/10/20082:14PMEdgar (US Regulatory)Manhattan Pharmaceuticals Inc-Nat'nl Sec. Exchg. Report the Removal from listing & reg. of matured, redeemed/retired sec. (25)AMEX:MHAManhattan Pharmaceuticals
      03/05/20084:19PMEdgar (US Regulatory)Manhattan Pharmaceuticals Inc - Statement of Beneficial Ownership (SC 13D)AMEX:MHAManhattan Pharmaceuticals
      02/28/20082:43PMEdgar (US Regulatory)Manhattan Pharmaceuticals Inc - Current report filing (8-K)AMEX:MHAManhattan Pharmaceuticals
      02/13/20085:12PMEdgar (US Regulatory)Manhattan Pharmaceuticals Inc - Amended Statement of Ownership (SC 13G/A)AMEX:MHAManhattan Pharmaceuticals
      02/06/20085:00PMEdgar (US Regulatory)Manhattan Pharmaceuticals Inc - Current report filing (8-K)AMEX:MHAManhattan Pharmaceuticals
      01/03/20082:56PMEdgar (US Regulatory)Manhattan Pharmaceuticals Inc - Current report filing (8-K)AMEX:MHAManhattan Pharmaceuticals
      12/10/20077:07AMBusiness WireAMEX Accepts Manhattan Pharmaceuticals' Plan to Regain Compliance with Continued Listing StandardsAMEX:MHAManhattan Pharmaceuticals
      11/14/200710:00AMEdgar (US Regulatory)Manhattan Pharmaceuticals Inc - Quarterly Report (10-Q)AMEX:MHAManhattan Pharmaceuticals
      10/03/20074:02PMEdgar (US Regulatory)Manhattan Pharmaceuticals Inc - Current report filing (8-K)AMEX:MHAManhattan Pharmaceuticals
      10/03/20074:02PMEdgar (US Regulatory)Manhattan Pharmaceuticals Inc - Current report filing (8-K)AMEX:MHAManhattan Pharmaceuticals
      09/21/20072:35PMEdgar (US Regulatory)Manhattan Pharmaceuticals Inc (Other) (8-K)AMEX:MHAManhattan Pharmaceuticals
      07/10/20077:00AMPR Newswire (US)Manhattan Pharmaceuticals Provides Update on Clinical PipelineAMEX:MHAManhattan Pharmaceuticals
      07/09/20074:30PMPR Newswire (US)Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estroneAMEX:MHAManhattan Pharmaceuticals
      06/27/20078:59AMPR Newswire (US)Manhattan Pharmaceuticals Acquires Hedrin(TM) for the Treatment of Head LiceAMEX:MHAManhattan Pharmaceuticals
      05/10/20079:29AMPR Newswire (US)Manhattan Pharmaceuticals Successfully Completes Dosing Portion of Two Phase 2a Clinical Trials of Oral Oleoyl-estrone for ObesiAMEX:MHAManhattan Pharmaceuticals
      04/04/20079:29AMPR Newswire (US)Manhattan Pharmaceuticals Announces License Agreement and Expanded PipelineAMEX:MHAManhattan Pharmaceuticals
      04/02/20079:29AMPR Newswire (US)Manhattan Pharmaceuticals Completes $8.6 Million Private PlacementAMEX:MHAManhattan Pharmaceuticals
      03/27/20079:29AMPR Newswire (US)AMEX Accepts Manhattan Pharmaceuticals' Plan to Regain Compliance With Continued Listing StandardsAMEX:MHAManhattan Pharmaceuticals
      02/21/20078:29AMPR Newswire (US)Manhattan Pharmaceuticals Completes Enrollment in Phase 2a Study of Oral Oleoyl-estrone for ObesityAMEX:MHAManhattan Pharmaceuticals
      11/08/20068:29AMPR Newswire (US)Manhattan Pharmaceuticals Expands Phase 2a Obesity Clinical Trial Sites to USAMEX:MHAManhattan Pharmaceuticals
      11/08/20068:29AMPR Newswire (US)Manhattan Pharmaceuticals Expands Phase 2a Obesity Clinical Trial Sites to USAMEX:MHAManhattan Pharmaceuticals
      10/12/20069:29AMPR Newswire (US)Manhattan Pharmaceuticals Expanding Oral Oleoyl-estrone Clinical Program to Include Morbidly ObeseAMEX:MHAManhattan Pharmaceuticals
      06/29/200611:29AMPR Newswire (US)Manhattan Pharmaceuticals Doses First Patient Group In Phase IIa Trial For OE, Its Oral Obesity Drug CandidateAMEX:MHAManhattan Pharmaceuticals
      05/16/20069:02AMPR Newswire (US)Manhattan Pharmaceuticals Receives SwissMedic's Approval to Commence Phase IIa Trial With OE, Its Oral Obesity Drug CandidateAMEX:MHAManhattan Pharmaceuticals
      12/28/200511:25AMPR Newswire (US)Manhattan Pharmaceuticals' Topical Psoriasis Treatment in Phase IIa TrialAMEX:MHAManhattan Pharmaceuticals
      10/07/20051:35PMPR Newswire (US)American Stock Exchange Lists Common Stock of Manhattan Pharmaceutical Inc.AMEX:MHA
       Showing the most relevant articles for your search:AMEX:MHA